1. Home
  2. KAVL vs VRAX Comparison

KAVL vs VRAX Comparison

Compare KAVL & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KAVL
  • VRAX
  • Stock Information
  • Founded
  • KAVL 1998
  • VRAX 2013
  • Country
  • KAVL United States
  • VRAX United Kingdom
  • Employees
  • KAVL N/A
  • VRAX N/A
  • Industry
  • KAVL Medicinal Chemicals and Botanical Products
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KAVL Health Care
  • VRAX Health Care
  • Exchange
  • KAVL Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • KAVL 11.0M
  • VRAX 7.3M
  • IPO Year
  • KAVL N/A
  • VRAX 2022
  • Fundamental
  • Price
  • KAVL $1.35
  • VRAX $1.66
  • Analyst Decision
  • KAVL
  • VRAX
  • Analyst Count
  • KAVL 0
  • VRAX 0
  • Target Price
  • KAVL N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • KAVL 663.8K
  • VRAX 256.7K
  • Earning Date
  • KAVL 03-24-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • KAVL N/A
  • VRAX N/A
  • EPS Growth
  • KAVL N/A
  • VRAX N/A
  • EPS
  • KAVL N/A
  • VRAX N/A
  • Revenue
  • KAVL $10,108,906.00
  • VRAX $84,872.00
  • Revenue This Year
  • KAVL $652.90
  • VRAX $5,169.18
  • Revenue Next Year
  • KAVL N/A
  • VRAX $66.97
  • P/E Ratio
  • KAVL N/A
  • VRAX N/A
  • Revenue Growth
  • KAVL N/A
  • VRAX 7.03
  • 52 Week Low
  • KAVL $0.58
  • VRAX $0.60
  • 52 Week High
  • KAVL $9.69
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • KAVL 59.13
  • VRAX 42.25
  • Support Level
  • KAVL $1.13
  • VRAX $1.56
  • Resistance Level
  • KAVL $1.42
  • VRAX $1.86
  • Average True Range (ATR)
  • KAVL 0.17
  • VRAX 0.19
  • MACD
  • KAVL 0.00
  • VRAX -0.04
  • Stochastic Oscillator
  • KAVL 72.49
  • VRAX 26.31

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: